A detailed history of Wells Fargo & Company transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Wells Fargo & Company holds 2,147 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,147
Previous 2,144 0.14%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
N/A
3 Added 0.14%
2,147 $0
Q4 2023

Feb 09, 2024

BUY
N/A
10 Added 0.47%
2,144 $0
Q3 2023

Nov 13, 2023

SELL
N/A
-4 Reduced 0.19%
2,134 $0
Q2 2023

Aug 15, 2023

SELL
N/A
-4,466 Reduced 67.63%
2,138 $0
Q1 2023

May 12, 2023

BUY
N/A
4,654 Added 238.67%
6,604 $0
Q4 2022

Feb 13, 2023

SELL
$0.0 - $9.95 $0 - $626
-63 Reduced 3.13%
1,950 $0
Q3 2022

Nov 14, 2022

SELL
$8.57 - $11.57 $2,322 - $3,135
-271 Reduced 11.87%
2,013 $18,000
Q2 2022

Aug 12, 2022

SELL
$8.84 - $11.64 $210,657 - $277,381
-23,830 Reduced 91.25%
2,284 $22,000
Q1 2022

May 16, 2022

SELL
$10.07 - $11.93 $280,711 - $332,560
-27,876 Reduced 51.63%
26,114 $303,000
Q4 2021

Feb 14, 2022

SELL
$7.95 - $11.24 $282,201 - $398,986
-35,497 Reduced 39.67%
53,990 $600,000
Q3 2021

Nov 15, 2021

BUY
$9.22 - $12.44 $564,098 - $761,104
61,182 Added 216.15%
89,487 $825,000
Q2 2021

Aug 16, 2021

SELL
$9.91 - $12.78 $481,784 - $621,312
-48,616 Reduced 63.2%
28,305 $319,000
Q1 2021

May 13, 2021

SELL
$10.44 - $12.22 $40,684 - $47,621
-3,897 Reduced 4.82%
76,921 $815,000
Q4 2020

Feb 09, 2021

BUY
$9.3 - $11.77 $9,532 - $12,064
1,025 Added 1.28%
80,818 $877,000
Q3 2020

Nov 05, 2020

SELL
$7.59 - $10.8 $50,815 - $72,306
-6,695 Reduced 7.74%
79,793 $775,000
Q2 2020

Aug 13, 2020

BUY
$7.96 - $11.54 $89,868 - $130,286
11,290 Added 15.01%
86,488 $688,000
Q1 2020

May 14, 2020

BUY
$7.69 - $11.68 $578,272 - $878,312
75,198 New
75,198 $654,000

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.